A Phase Ib Study of BEZ235, a Dual Inhibitor of...

The Oncologist 2016 / 06

A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma

Carlo, M. I., Molina, A. M., Lakhman, Y., Patil, S., Woo, K., DeLuca, J., Lee, C.-H., Hsieh, J. J., Feldman, D. R., Motzer, R. J., H. Voss, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2016-0145
Date:
June, 2016
File:
PDF, 538 KB
english, 2016
Conversion to is in progress
Conversion to is failed